Paper28126011
Metformin targets multiple signaling pathways in cancer.
Lei Y and 7 others. Chin J Cancer, 2017. Cited by 120 papers, by iCite.
Cite this record
ConductScience Library. Metformin targets multiple signaling pathways in cancer. Papers, record 28126011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28126011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Metformin | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Humans | |
| Hypoglycemic Agents | |
| Neoplastic Stem Cells | |
| Signal Transduction |
Source PubMed
References128
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12471242 | Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. | Science | 2002 | https://conductscience.org/library/papers/12471242 | PubMed |
| 2 | 17062558 | Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. | Cancer Res | 2006 | https://conductscience.org/library/papers/17062558 | PubMed |
| 3 | 20363874 | AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. | Mol Endocrinol | 2010 | https://conductscience.org/library/papers/20363874 | PubMed |
| 4 | 14601044 | The IGF-1 receptor in cancer biology. | Int J Cancer | 2003 | https://conductscience.org/library/papers/14601044 | PubMed |
| 5 | 19221486 | Mitotic kinase dynamics of the active form of AMPK (phospho-AMPKalphaThr172) in human cancer cells. | Cell Cycle | 2009 | https://conductscience.org/library/papers/19221486 | PubMed |
| 6 | 17085648 | Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/17085648 | PubMed |
| 7 | 23942093 | Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23942093 | PubMed |
| 8 | 19440038 | Metformin induces unique biological and molecular responses in triple negative breast cancer cells. | Cell Cycle | 2009 | https://conductscience.org/library/papers/19440038 | PubMed |
| 9 | 23663483 | Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23663483 | PubMed |
| 10 | 17355113 | The transcription factor nuclear factor-kappa B and cancer. | Clin Oncol (R Coll Radiol) | 2007 | https://conductscience.org/library/papers/17355113 | PubMed |
| 11 | 21540236 | Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. | Cancer Res | 2011 | https://conductscience.org/library/papers/21540236 | PubMed |
| 12 | 17712357 | AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. | Nat Rev Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17712357 | PubMed |
| 13 | 22643892 | Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. | Nat Commun | 2012 | https://conductscience.org/library/papers/22643892 | PubMed |
| 14 | 25556614 | The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges. | Chin J Cancer | 2015 | https://conductscience.org/library/papers/25556614 | PubMed |
| 15 | 16286006 | mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. | Cell | 2005 | https://conductscience.org/library/papers/16286006 | PubMed |
| 16 | 20234352 | mTOR signaling and drug development in cancer. | Nat Rev Clin Oncol | 2010 | https://conductscience.org/library/papers/20234352 | PubMed |
| 17 | 25421433 | Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro. | Oncol Rep | 2015 | https://conductscience.org/library/papers/25421433 | PubMed |
| 18 | 18212742 | The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. | Oncogene | 2008 | https://conductscience.org/library/papers/18212742 | PubMed |
| 19 | 15314020 | Upstream and downstream of mTOR. | Genes Dev | 2004 | https://conductscience.org/library/papers/15314020 | PubMed |
| 20 | 24644001 | Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24644001 | PubMed |
Cited by91
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948351 | Metformin Attenuates Glucose-Driven Hepatocellular Carcinoma Progression by Targeting GPD2-Mediated Metabolic Plasticity. | Scientifica (Cairo) | 2026 | https://conductscience.org/library/papers/42948351 | PubMed |
| 42358944 | Combination of metformin and parthenolide inhibits breast cancer in mice by apoptosis induction and angiogenesis inhibition. | Front Immunol | 2026 | https://conductscience.org/library/papers/42358944 | PubMed |
| 42199344 | Coconut oil/lauric acid-based nanodrug formulation: a multifunctional platform for enhancing cancer therapy and mitigating toxicity. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42199344 | PubMed |
| 41899438 | From Metabolism to Longevity: Molecular Mechanisms Underlying Metformin's Anticancer and Anti-Aging Effects. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41899438 | PubMed |
| 41893042 | Metformin Renders Survival Advantage to Patients with Glioblastoma Multiforme. | Neurol Int | 2026 | https://conductscience.org/library/papers/41893042 | PubMed |
| 41326661 | Deciphering genetic susceptibility to clear cell renal cell carcinoma. | Commun Biol | 2025 | https://conductscience.org/library/papers/41326661 | PubMed |
| 40901390 | Antitumor Effects of Metformin in Squamous Cell Carcinoma under Leptin Treatment Conditions. | Prev Nutr Food Sci | 2025 | https://conductscience.org/library/papers/40901390 | PubMed |
| 40737255 | Effects of long-term metformin intake on postoperative clinicopathological characteristics in patients with invasive lung adenocarcinoma and type 2 diabetes mellitus: A retrospective analysis. | PLoS One | 2025 | https://conductscience.org/library/papers/40737255 | PubMed |
| 40387523 | Therapeutic Potential of Anti-Diabetes Drugs and Anti-Dyslipidemia Drugs to Mitigate Head and Neck Cancer Risk in Metabolic Syndrome. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/40387523 | PubMed |
| 40115422 | Enhanced integrated therapy for breast cancer employing Honokiol-loaded mesoporous polydopamine nanoparticles in conjunction with photothermal effects and low-dose metformin. | APL Bioeng | 2025 | https://conductscience.org/library/papers/40115422 | PubMed |
| 40091035 | Investigation of the synergistic effect of metformin and FX11 on PANC-1 cell lines. | Biol Res | 2025 | https://conductscience.org/library/papers/40091035 | PubMed |
| 40048168 | Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40048168 | PubMed |
| 39970627 | Metformin and glioma: Targeting metabolic dysregulation for enhanced therapeutic outcomes. | Transl Oncol | 2025 | https://conductscience.org/library/papers/39970627 | PubMed |
| 39959483 | Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers. | Heliyon | 2025 | https://conductscience.org/library/papers/39959483 | PubMed |
| 39872949 | A comparative study of metformin and nicotinamide riboside in alleviating tissue aging in rats. | Life Med | 2023 | https://conductscience.org/library/papers/39872949 | PubMed |
| 39844411 | Preventive and Therapeutic effects of Metformin in Cancer: A Meta- Analysis of RCT and Cohort Studies. | Curr Cancer Drug Targets | 2026 | https://conductscience.org/library/papers/39844411 | PubMed |
| 39634308 | Highly active selenium nanotherapeutics combined with metformin to achieve synergistic sensitizing effect on NK cells for osteosarcoma therapy. | Nanophotonics | 2022 | https://conductscience.org/library/papers/39634308 | PubMed |
| 39561737 | Combination Therapy with Secretome of Reovirus-Infected Mesenchymal Stem Cells and Metformin Improves Anticancer Effects of Irinotecan on Colorectal Cancer Cells in vitro. | Intervirology | 2025 | https://conductscience.org/library/papers/39561737 | PubMed |
| 39337118 | Metformin Treatment Is Not Associated with Altered PD-L1 Expression in Diabetic Patients with Oral Squamous Cell Carcinoma. | J Clin Med | 2024 | https://conductscience.org/library/papers/39337118 | PubMed |
| 39063589 | Comprehensive Evaluation of a Levonorgestrel Intrauterine Device (LNG-IUD), Metformin, and Liraglutide for Fertility Preservation in Endometrial Cancer: Protocol for a Randomized Clinical Trial. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39063589 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28126011
GET https://conductscience.org/api/papers/v1/28126011/references?page=2